Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline

被引:196
作者
Daly, Megan E. [1 ]
Singh, Navneet [2 ]
Ismaila, Nofisat [3 ]
Antonoff, Mara B. [4 ]
Arenberg, Douglas A. [5 ]
Bradley, Jeffrey [6 ]
David, Elizabeth [7 ]
Detterbeck, Frank [8 ]
Fruh, Martin [9 ,10 ]
Gubens, Matthew A. [11 ]
Moore, Amy C. [12 ]
Padda, Sukhmani K. [13 ]
Patel, Jyoti D. [14 ]
Phillips, Tanyanika [15 ]
Qin, Angel
Robinson, Clifford [16 ]
Simone, Charles B., II [17 ,18 ]
机构
[1] Univ Calif Davis, Davis, CA USA
[2] Postgrad Inst Med Educ & Res, Chandigarh, India
[3] Amer Soc Clin Oncol ASCO, Alexandria, VA USA
[4] MD Anderson Canc Ctr, Houston, TX USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Emory Univ, Atlanta, GA 30322 USA
[7] Univ Southern Calif, Los Angeles, CA 90007 USA
[8] Yale Canc Ctr, New Haven, CT USA
[9] Cantonal Hosp St Gallen, Dept Med Oncol, St Gallen, Switzerland
[10] Univ Bern, Bern, Switzerland
[11] Univ Calif San Francisco, San Francisco, CA USA
[12] LUNGev Fdn, Chicago, IL USA
[13] Cedars Sinai Med Ctr, Div Oncol, Dept Med, Los Angeles, CA USA
[14] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[15] City Hope Natl Med Ctr, Lancaster, CA USA
[16] Washington Univ, St Louis, MO 63110 USA
[17] New York Proton Ctr, New York, NY USA
[18] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
关键词
RANDOMIZED PHASE-III; THERAPY-ONCOLOGY-GROUP; HYPERFRACTIONATED ACCELERATED RADIOTHERAPY; COMPARING CONCOMITANT RADIOCHEMOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; COMBINED-MODALITY TREATMENT; THORACIC RADIATION-THERAPY; TYROSINE KINASE INHIBITORS; CONCURRENT CHEST RADIATION; TRIALIST ASSOCIATION ANITA;
D O I
10.1200/JCO.21.02528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non-small-cell lung cancer (NSCLC). METHODS An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary oncology, community oncology, research methodology, and advocacy experts was convened to conduct a literature search, which included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS The literature search identified 127 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS Evidence-based recommendations were developed to address evaluation and staging workup of patients with suspected stage III NSCLC, surgical management, neoadjuvant and adjuvant approaches, and management of patients with unresectable stage III NSCLC. (C) 2021 by American Society of Clinical Oncology
引用
收藏
页码:1356 / +
页数:31
相关论文
共 216 条
[1]   Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04 [J].
Ahn, Jin Seok ;
Ahn, Yong Chan ;
Kim, Joo-Hang ;
Lee, Chang Geol ;
Cho, Eun Kyung ;
Lee, Kyu Chan ;
Chen, Ming ;
Kim, Dong-Wan ;
Kim, Hoon-Kyo ;
Min, Young Joo ;
Kang, Jin-Hyoung ;
Choi, Jin-Hyuck ;
Kim, Sang-We ;
Zhu, Guangying ;
Wu, Yi-Long ;
Kim, Sung Rok ;
Lee, Kyung Hee ;
Song, Hong Suk ;
Choi, Yoon-La ;
Sun, Jong-Mu ;
Jung, Sin-Ho ;
Ahn, Myung-Ju ;
Park, Keunchil .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) :2660-U124
[2]   Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial [J].
Albain, Kathy S. ;
Swann, R. Suzanne ;
Rusch, Valerie W. ;
Turrisi, Andrew T., III ;
Shepherd, Frances A. ;
Smith, Colum ;
Chen, Yuhchyau ;
Livingston, Robert B. ;
Feins, Richard H. ;
Gandara, David R. ;
Fry, Willard A. ;
Darling, Gail ;
Johnson, David H. ;
Green, Mark R. ;
Miller, Robert C. ;
Ley, Joanne ;
Sause, Willliam T. ;
Cox, James D. .
LANCET, 2009, 374 (9687) :379-386
[3]  
American Cancer Society, 2020, Cancer Facts & Figures 2020
[4]   Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer A Randomized Trial [J].
Annema, Jouke T. ;
van Meerbeeck, Jan P. ;
Rintoul, Robert C. ;
Dooms, Christophe ;
Deschepper, Ellen ;
Dekkers, Olaf M. ;
De Leyn, Paul ;
Braun, Jerry ;
Carroll, Nicholas R. ;
Praet, Marleen ;
de Ryck, Frederick ;
Vansteenkiste, Johan ;
Vermassen, Frank ;
Versteegh, Michel I. ;
Veselic, Maud ;
Nicholson, Andrew G. ;
Rabe, Klaus F. ;
Tournoy, Kurt G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (20) :2245-2252
[5]  
[Anonymous], 1995, Eur J Surg Oncol, V21, P69
[6]  
[Anonymous], 2015, United States Cancer Statistics: 1999-2012 Incidence and Mortality Web-based Report
[7]  
[Anonymous], 2003, COCHRANE DB SYST REV, V1
[8]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[9]   Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Yokoi, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
de Castro Carpeno, J. ;
Wadsworth, C. ;
Melillo, G. ;
Jiang, H. ;
Huang, Y. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929
[10]   Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer [J].
Arriagada, Rodrigo ;
Dunant, Ariane ;
Pignon, Jean-Pierre ;
Bergman, Bengt ;
Chabowski, Mariusz ;
Grunenwald, Dominique ;
Kozlowski, Miroslaw ;
Le Pechoux, Cecile ;
Pirker, Robert ;
Pinel, Maria-Izabel Sathler ;
Tarayre, Michele ;
Le Chevalier, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :35-42